Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacometabolomics reveals racial differences in response to atenolol treatment.

PloS one - 1 Jan 2013

Wikoff William R, Frye Reginald F, Zhu Hongjie, Gong Yan, Boyle Stephen, Churchill Erik, Cooper-Dehoff Rhonda M, Beitelshees Amber L, Chapman Arlene B, Fiehn Oliver, Johnson Julie A, Kaddurah-Daouk Rima

Abstract excerpt

Antihypertensive drugs are among the most commonly prescribed drugs for chronic disease worldwide. The response to antihypertensive drugs varies substantially between individuals and important factors such as race that contribute to this heterogeneity are poorly understood. In this study we use m...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antihypertensive Agents
Share to Black or African American

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cluster Analysis

Share to Hypertension

Share to Metabolic Networks and Pathways

Share to Metabolome

Share to Metabolomics

Share to Pharmacogenetics

Source

Open in PubMed Open full text

Identifiers

PMID: 23536766
DOI: 10.1371/journal.pone.0057639
PMCID: PMC3594230

Genes

LIPC

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23536766-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacometabolomics reveals racial differences in response to atenolol treatment.PMID 23536766Read ↗

Metabolomic strategies to identify tissue-specific effects of cardiovascular drugs.Semantic proximity Read ↗

Atenolol induced HDL-C change in the pharmacogenomic evaluation of antihypertensive responses (PEAR) study.Semantic proximity Read ↗

Serum metabolites associate with lipid phenotypes among Bogalusa Heart Study participants.Semantic proximity Read ↗

Metabolomics: a global biochemical approach to drug response and disease.Semantic proximity Read ↗

A treasure of pharmacogenomic insights into postprandial lipoproteinemia and therapeutic responses to fibrate therapy: lessons from GOLDN.Semantic proximity Read ↗

Ancestry-driven metabolite variation provides insights into disease states in admixed populations.Semantic proximity Read ↗

Metabolomic strategies to study lipotoxicity in cardiovascular diseaseSemantic proximity Read ↗

Integrated untargeted/targeted metabolomics identifies a putative oxylipin signature in patients with atrial fibrillation and coronary heart diseaseSemantic proximity Read ↗

Plasma acylcarnitines and gut‐derived aromatic amino acids as sex‐specific hub metabolites of the human aging metabolomeSemantic proximity Read ↗

Metabolic profiling in diabetes.Semantic proximity Read ↗

FALCON systematically interrogates free fatty acid biology and identifies a novel mediator of lipotoxicitySemantic proximity Read ↗

An untargeted metabolomics study of blood pressure: findings from the Bogalusa Heart Study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.